Weekly IDEXX Laboratories, Inc. (NASDAQ:IDXX) Ratings as of May 16, 2018

May 16, 2018 - By Rebecca Betts

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Corporate Logo
During Q4 2017 the big money sentiment decreased to 0.81. That’s change of 0.05, from 2017Q3’s 0.86. 30 investors sold all, 217 reduced holdings as IDEXX Laboratories, Inc. ratio turned negative. 137 rose holdings while 64 funds bought holdings. Funds hold 72.13 million shares thus 17.89% less from 2017Q3’s 87.85 million shares.
Art Advsr Ltd Liability holds 0.09% or 13,300 shs. 34,764 are held by Balyasny Asset Mgmt Ltd Limited Liability Company. Veritable Limited Partnership invested in 3,702 shs. Aperio Ltd Liability has invested 0.03% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Century Inc owns 946,391 shs. San Francisco Sentry (Ca) accumulated 90 shs or 0% of the stock. Qs Invsts Llc has invested 0.01% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX). American Capital Inc reported 519,833 shs. Ameriprise Financial holds 106,179 shs. Eaton Vance reported 81,075 shs. Gam Ag has 3,745 shs for 0.02% of their capital. Spinnaker Tru has 4,500 shs. 58,800 are owned by Bridgeway Capital Management. Renaissance Techs Ltd Co invested in 1.88M shs. Paloma Mgmt holds 0.03% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 13,804 shs.

IDEXX Laboratories, Inc. had 7 insider sales and 2 buys since January 9, 2018. This’s net activity of $23.44 million. On Wednesday, February 28 JUNIUS DANIEL M sold $565,232 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 2,974 shs. On Thursday, February 22 4,000 shs were sold by END WILLIAM T, worth $737,939. On Wednesday, February 14 Kingsley Lawrence D also bought $178,045 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX). 6,602 shs were sold by MCKEON BRIAN P, worth $1.20M on Monday, February 5. Another trade for 1,000 shs valued at $179,580 was made by Claflin Bruce L. on Wednesday, February 7.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Ratings Coverage

Total analysts of 5 have positions in IDEXX Laboratories (NASDAQ:IDXX) as follows: 5 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since January 16, 2018 according to StockzIntelligence Inc IDEXX Laboratories has 7 analyst reports. On Monday, January 29 the rating was maintained by Canaccord Genuity with “Buy”. On Monday, May 7 the stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by Stifel Nicolaus. On Friday, February 2 the stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) has “Buy” rating given by Bank of America. On Monday, May 7 the firm has “Buy” rating by Canaccord Genuity given. On Thursday, February 1 the stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by Stifel Nicolaus. Listed here are IDEXX Laboratories, Inc. (NASDAQ:IDXX) PTs and latest ratings.

07/05/2018 Broker: Canaccord Genuity Rating: Buy New Target: $225.0000 Maintain
07/05/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Buy Old Target: $215 New Target: $225 Maintain
02/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $200 New Target: $220 Maintain
01/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $215.0 Maintain
01/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $211.0
29/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $210.0 Maintain
16/01/2018 Broker: PiperJaffray Rating: Overweight New Target: $200 Initiates Coverage On

Ticker’s shares touched $199.54 during the last trading session after 4.49% change.IDEXX Laboratories, Inc. is uptrending after having risen 23.99% since May 16, 2017. IDXX has 1.12 million volume or 139.04% up from normal. IDXX outperformed the S&P 500 by 12.44%.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.The firm is worth $17.33 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions.The P/E ratio is 67.87. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

More recent IDEXX Laboratories, Inc. (NASDAQ:IDXX) news were announced by Nasdaq.com, Fool.com and Seekingalpha.com. The first one has “IDEXX Laboratories Barks Out Another Successful Quarter” as a title and was announced on May 11, 2018. The next is “The 3 Stocks on the MFM Team’s Radar This Week” on May 10, 2018. And last was announced on May 14, 2018, called “Buy Diamondback Energy On Declines – Cramer’s Lightning Round (5/11/18)”.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: